Patent intelligence Β· AU
AU 2024268154
NOVEL CARBOXAMIDE DERIVATIVES
NOVEL CARBOXAMIDE DERIVATIVES
Patent details β AU 2024268154
- Jurisdiction
- AU
- Status
- granted
- Grant date
- Nov 13, 2025
- Expiration
- Nov 8, 2045
- Applicant
- ANGELINI PHARMA S P A [IT]
- CPC classes
- A61K 31/ 165 A I, A61K 31/ 4427 A I, A61K/31165, A61P/2500
Quick answer
AU 2024268154 (NOVEL CARBOXAMIDE DERIVATIVES) is held by ANGELINI PHARMA S P A [IT]. Status: granted. Granted Nov 13, 2025. Expires Nov 8, 2045 (19 years remaining) β relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ANGELINI PHARMA S P A [IT]
- Grant date
- Expiration
- Claims
- β
- CPC classes
- A61K 31/ 165 A I, A61K 31/ 4427 A I, A61K/31165, A61P/2500
More from ANGELINI PHARMA S P A [IT]
Related pharmaceutical patents in our USPTO index.
-
WO 2025252600
COMPOSΓS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3
granted -
WO 2025252599
COMPOSΓS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3
granted -
IT 202300027246
Matrici farmaceutiche per il rilascio prolungato di farmaci
granted -
IT 202200024948
Composti attivatori dei canali potassio KV7.2/KV7.3
granted -
IT 202200024963
Composti attivatori dei canali potassio Kv7.2/Kv7.3
granted -
AU 2022390453
NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS
granted
Frequently asked questions
What is US patent 2024268154?
AU 2024268154 (NOVEL CARBOXAMIDE DERIVATIVES) is held by ANGELINI PHARMA S P A [IT]. Status: granted. Granted Nov 13, 2025. Expires Nov 8, 2045 (19 years remaining) β relevant for patent-cliff and LOE planning.
Who owns AU 2024268154?
ANGELINI PHARMA S P A [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does AU 2024268154 expire?
Our index shows an expiration date of Nov 8, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.